Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Laws

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Annals of Surgical Oncology|July 9, 2022
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast CancerAlison Laws, Ricardo Pastorello, Tanujit Dey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 21, 2020
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancerRicardo G Pastorello, Alison Laws, Samantha Grossmith, et al.
Annals of Surgical Oncology|May 6, 2021
Comparison of Breast Cancer Staging Systems After Neoadjuvant ChemotherapyOlga Kantor, Alison Laws, Ricardo G Pastorello, et al.
Annals of Surgical Oncology|July 26, 2019
Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 Breast LesionsAlison Laws, Alysha Crocker, Joseph Dort, et al.
Breast Cancer Research and Treatment|April 5, 2022
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifenBrittany Bychkovsky, Alison Laws, Fisher Katlin, et al.
Annals of Surgical Oncology|July 20, 2020
Baseline Screening MRI Uptake and Findings in Women with ≥ 20% Lifetime Risk of Breast CancerAlison Laws, Therese M Mulvey, Nicole Jalbert, et al.
Annals of Surgical Oncology|August 3, 2020
Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive LocalizersAlison Laws, Kayla Dillon, Bridget N Kelly, et al.
Annals of Surgical Oncology|December 10, 2023
Long-Term Patient-Reported Arm Symptoms in Breast Cancer SurvivorsAlison Laws, Mirelle Lagendijk, Samantha Grossmith, et al.
Annals of Surgical Oncology|July 12, 2023
Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront MastectomyRobert M Pride, Charity C Glass, Faina Nakhlis, et al.
Annals of Surgical Oncology|May 11, 2023
Value of Ambulatory Modified Radical MastectomyAva Ferguson Bryan, Manuel Castillo-Angeles, Christina Minami, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|July 9, 2022
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast CancerAlison Laws, Ricardo Pastorello, Tanujit Dey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 21, 2020
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancerRicardo G Pastorello, Alison Laws, Samantha Grossmith, et al.
Annals of Surgical Oncology|May 6, 2021
Comparison of Breast Cancer Staging Systems After Neoadjuvant ChemotherapyOlga Kantor, Alison Laws, Ricardo G Pastorello, et al.
Annals of Surgical Oncology|July 26, 2019
Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 Breast LesionsAlison Laws, Alysha Crocker, Joseph Dort, et al.
Breast Cancer Research and Treatment|April 5, 2022
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifenBrittany Bychkovsky, Alison Laws, Fisher Katlin, et al.
Annals of Surgical Oncology|July 20, 2020
Baseline Screening MRI Uptake and Findings in Women with ≥ 20% Lifetime Risk of Breast CancerAlison Laws, Therese M Mulvey, Nicole Jalbert, et al.
Annals of Surgical Oncology|August 3, 2020
Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive LocalizersAlison Laws, Kayla Dillon, Bridget N Kelly, et al.
Annals of Surgical Oncology|December 10, 2023
Long-Term Patient-Reported Arm Symptoms in Breast Cancer SurvivorsAlison Laws, Mirelle Lagendijk, Samantha Grossmith, et al.
Annals of Surgical Oncology|July 12, 2023
Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront MastectomyRobert M Pride, Charity C Glass, Faina Nakhlis, et al.
Annals of Surgical Oncology|May 11, 2023
Value of Ambulatory Modified Radical MastectomyAva Ferguson Bryan, Manuel Castillo-Angeles, Christina Minami, et al.
Pageof 5